2024年10月4日 · The revised phase 2 trial accrued 382 patients in total (90.6% men, 87.5% White, and 84.9% with stage I disease). Moreover, 79.4% of the participants had never smoked, whereas 20.3% had a smoking ...

Prevention and Treatment of Oropharyngeal Mucositis: Current Status. ... Transforming growth factor-beta 3 (TGF-β3) is a known inhibitor of epithelial cell growth in G1 phase ...

October 17, 2011 — A simple oropharyngeal exam can provide key information regarding the severity of obstructive sleep apnea syndrome (OSAS), according to results from a study of more than 300 ...

2025年2月10日 · Breaking down results by cancer type, they found that oropharyngeal, hypopharyngeal, and oral cavity cancer risk was also significantly lowered with daily coffee consumption.

2024年8月12日 · The FDA approval was based on data from the company's phase 2 PaTH Forward trial and the Phase 3 PaTHway trial. In both, the drug was associated with normalization of serum calcium levels and ...

2025年1月13日 · Neoadjuvant chemotherapy followed by transoral robotic surgery (NECTORS) and neck dissection led to better survival outcomes in HPV-related oropharyngeal squamous cell carcinoma.

2015年2月17日 · Of the patients with HPV-positive oropharyngeal cancer and distant metastases, 10% survived more than 2 years after intensive treatment, which the researchers defined as a cure.

2024年3月22日 · Identifying sarcopenia early in patients with oropharyngeal squamous cell carcinoma can help predict the need for feeding tube placement. This site is intended for healthcare professionals .

2011年10月5日 · If the current trends continue, HPV-related oropharyngeal cancer will become the major form of head and neck cancer by 2020, and will become the leading HPV-associated cancer in the United States ...

A 2021 phase 3 trial reported by Medscape Medical News showed that radiotherapy de-escalation for patients with oral cancer can result in robust responses and lower toxicity. This finding aligned ...